SCHEMBL12825311

SCHEMBL12825311

NCCC(C(=O)Nc1ccc2[nH]nc(Nc3ccccc3)c2c1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 6/20 0.53
▸ ULK1 O75385 4/20 0.52
▸ TTK P33981 2/20 0.51
▸ ROCK1 Q13464 4/20 0.46
▸ MAPK1 P28482 3/20 0.46
▸ CDK2 P24941 2/20 0.46
▸ CDC7 O00311 1/20 0.46
▸ PLK4 O00444 1/20 0.46
▸ CHEK1 O14757 1/20 0.46
▸ DCLK1 O15075 1/20 0.46
▸ MAPK13 O15264 1/20 0.46
▸ PDPK1 O15530 1/20 0.46
▸ DAPK3 O43293 1/20 0.46
▸ DYRK3 O43781 1/20 0.46
▸ RPS6KA5 O75582 1/20 0.46
▸ PRKD3 O94806 1/20 0.46
▸ MAP4K4 O95819 1/20 0.46
▸ PAK4 O96013 1/20 0.46
▸ CHEK2 O96017 1/20 0.46
▸ PRKCG P05129 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12826136 0.92 TTK (0.50) ROCK2ULK1TTKROCK1MAPK1
SCHEMBL12825419 0.89 TTK (0.46) ROCK2ULK1TTKROCK1MAPK1
SCHEMBL12825520 0.87 JAK2 (0.59) ROCK2ULK1TTKROCK1MAPK1
SCHEMBL12826120 0.84 ROCK2 (0.47) ROCK2ULK1TTKROCK1MAPK1
SCHEMBL12825316 0.84 TTK (0.62) ROCK2TTKROCK1MAPK1CDK2
SCHEMBL12825525 0.83 GSK3B (0.56) ROCK2ULK1TTKROCK1MAPK1
SCHEMBL12825521 0.83 TTK (0.49) ROCK2ULK1TTKROCK1MAPK1
SCHEMBL12826119 0.82 ROCK2 (0.48) ROCK2ULK1TTKROCK1MAPK1
SCHEMBL12825406 0.82 TTK (0.66) ROCK2TTKPLK4CHEK2AURKB
SCHEMBL12825317 0.81 TTK (0.57) ROCK2ULK1TTKROCK1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2295413-A1 Indazole compounds useful as protein kinase inhibitors Vertex Pharmaceuticals Incorporated (US) 2011-03-16 — — EP disclosed
Send feedback